SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1044NTII's website (the IR page) has a link to Paul F's Monday presentation lrb-9/18/2001
1043<<<< It's worth noting that because we are dealing only with useJohn McCarthy-9/3/2001
1042gliomas might spread by releasing glutamate to destroy surrounding brain cells. John McCarthy-9/3/2001
1041Thanks, John. Very interesting set of posts indeed. Where did you find some of tBiomaven-8/31/2001
1040Thanks for the link. The Yahoo! thread has lots of good recap on the conf. callJMarcus-8/27/2001
1039NTII Timeline ............ messages.yahoo.comJohn McCarthy-8/27/2001
1038messages.yahoo.comJohn McCarthy-8/27/2001
1037Have you listened to the conf. call yet? I hope to do that this evening. -----JMarcus-8/27/2001
1036<b>Memantine Looks Promising for Moderate to Severe AD</b> MemantinJohn McCarthy-8/26/2001
1035<B> CHICAGO, Jul 17, 2001 /PRNewswire via COMTEX/ Forest Laboratories, DJohn McCarthy-8/26/2001
1034<B>Difference in the structure of NMDA and AMPA glutamate receptor channelJohn McCarthy-8/26/2001
1033<B>A pilot study of memantine for the treatment of heroin dependence</BJohn McCarthy-8/26/2001
1032As I can see NITT is not so bullish...I didn't buy double concentration of mel paradisio-8/21/2001
1031Size of Diabetic Neuropathic Pain Market One opinion ... BTGC News release ...John McCarthy-8/2/2001
1030Press Release Thursday August 2, 7:02 am Eastern Time Neurobiological TechnologJohn McCarthy-8/2/2001
1029<b>LE Magazine July 2001</b> <<<<<<<<<&lJohn McCarthy-7/29/2001
1028Thanks for the link. Nice to hear Memantine described as "the most promisiJMarcus-7/13/2001
1027biz.yahoo.comJohn McCarthy-7/12/2001
1026Diabetic neuropathic pain Phase 3 is by: a1stargazer 06/28/01 06:45 pm Msg: 10John McCarthy-6/29/2001
1025Neurobiological Technologies Summarizes Data for Memantine sim1-5/16/2001
1024FRX Press Release re Memantine: biz.yahoo.com "Forest intends to submit anRCMac-5/10/2001
1023and what were the results ? Stefaandalroi-3/14/2001
1022American Academy of Neurology - Abstract Date/Time: Friday, May 11, 2001 2:30 PDr. John M. de Castro-3/14/2001
1021Taglich Brothers Announces Investment Opinion on Neurobiological Technologies, IJohn McCarthy-2/8/2001
1020Forest Laboratories Announces Product Developments For Memantine, Alvameline andJohn McCarthy-1/30/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News